Stocktoria
Cresco Labs Inc. CRLBF
Cresco Labs Inc. (CRLBF) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $655.8M at a -20.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.59 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1995 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.133 |
| Retained earnings / assets | -1.253 |
| EBIT / assets | -0.023 |
| Equity / liabilities | 0.36 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CRLBF | Cresco Labs Inc. | 3/9 | -2.99 | — | -9.5% |
| AAWH | Ascend Wellness Holdings, Inc. | 4/9 | -1.32 | — | -10.9% |
| TLRY | Tilray Brands, Inc. | 2/9 | -3.61 | — | +11.5% |
| USNA | USANA HEALTH SCIENCES INC | 6/9 | 7.37 | 32.6 | +8.3% |
| CGC | Canopy Growth Corp | 4/9 | — | — | +10.5% |
| JUSHF | Jushi Holdings Inc. | 3/9 | -4.96 | — | +2.1% |
| CRON | Cronos Group Inc. | 6/9 | — | — | +19.5% |
About Cresco Labs Inc.
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
FAQ
Is CRLBF financially healthy?
Cresco Labs Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CRLBF pay a dividend?
No, Cresco Labs Inc. does not currently pay a dividend.
How profitable is CRLBF?
In FY2025, Cresco Labs Inc. had a net margin of -20.6% and a return on equity of -39.8%.
What is the analyst price target for CRLBF?
The average Wall-Street price target for Cresco Labs Inc. is $2.00, about 172.1% above the recent price, from 1 analysts.
Is CRLBF a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Cresco Labs Inc.: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.